Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Roche Sees Covid-19 Antibody Delivery in First Quarter
Posted
November 20, 2020
Views
310
Likes
2
Engagement
0.65%
November 20, 2020
310
2
0.65%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
0:58Now PlayingRoche Holding AG is working hard to rapidly boost supply of Covid-19 antibody treatments and will be able to make its first deliveries in the first quarter of next year, according to Chief Executive Officer Severin Schwan.
U.S. biotech Regeneron Pharmaceuticals Inc. has filed in the U.S. for emergency authorization for an antibody cocktail it’s working on with Roche and that could be granted “very soon,” Schwan said Friday in an interview with Bloomberg Television.
“At Roche we’ll be able to provide supply in the first quarter,” he added, cautioning that availability will initially be limited and should be reserved for patients at high risk.
The two companies’ combined capacity next year will be about 2 million doses, Schwan said. That’s about half the number of new Covid-19 cases identified around the world last week, according to the World Health Organization.
The need for a broad range of treatment options has come into increased focus as some hoped-for therapies, including Gilead Sciences Inc.’s antiviral remdesivir, fall short.
“We’re working hard to ramp up production as fast as we can,” Schwan said. “No matter what, irrespective of other therapeutics, the demand for antibody cocktails will by far outstrip supply, so we have to make sure we target really the right patient groups.”
In the longer term, Roche is working to increase capacity, he said. The companies signed an agreement to work together on the two-antibody cocktail in August. Regeneron will distribute the medicine inside the U.S., while Roche handles distribution elsewhere.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
